Articles

Podcasts

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

The pooled proportions of virological relapse and clinical relapse after discontinuing treatment in cirrhotic patients was 55.23 and 43.56%, respectively. 

High Relapse Rate After Discontinuing Antiviral Therapy for HBV Patients With Cirrhosis

The incidence of NAFLD was 263.9 cases per 100,000 person-years in the infectious mononucleosis group, compared to 164.5 cases per 100,000 person-years in individuals without it. 

Infectious Mononucleosis Increases the Risk of NAFLD

HBsAg-positive women with adequate gestational weight again among pre-pregnancy normal-weight women had a higher risk of gestational diabetes mellitus than HBs-Ag-negative women.

HBsAg-Positive Status, Excessive Gestational Weight Gain Risk Factors for Gestational Diabetes Mellitus

For NASH or NAFLD publications, the number of publications were on a continuous upward slope throughout the study period and finally surpassed HCV studies in 2020. 

NASH, NAFLD Studies Finally Surpassing HCV Studies

There was a similar prevalence of NAFLD in patients who were overweight as there was for individuals who were obese. 

Prevalence of NAFLD, NASH High in Overweight, Obese Population

The mean daily adherence was higher in the mDOT group compared to the patient navigation group.

Sustained Virologic Response Possible for HCV Drug Users With Patient-Centered Programs

Overall, 82 participants agreed to receive DBS testing, 28% of which reported that the aspects of the program made them feel uncomfortable.

Dried Blood Sample Testing Found Acceptable for Hepatitis B Virus Screenings

The efficacy of H pylori treatments has waned in recent years, largely because of clarithromycin resistance. 

High Hopes for New H Pylori Treatments

The FDA recently approved a drug treatment for HBV infection for pediatric patients 12 and older with compensated liver disease.

FDA Approves Tenofovir Alafenamide Treatment for Chronic Hepatitis B Virus in Pediatric Patients 12 and Older

Patients with NAFLD were more likely to have comorbidities, including diabetes, hypertension, chronic respiratory disease, hypothyroidism, chronic kidney disease, sleep apnea, and hyperlipidemia.

Patients with HIV and NAFLD at an Increased Risk of Cardiovascular Disease

Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.

Hepatitis C

Latest News